Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
Earth Erowid, Fire Erowid, Albert Garcia‐romeu, Alan K. Davis, Roland R. Griffiths, Matthew W. Johnson
Frontiers in Psychiatry January 22, 2020 DOI: 10.3389/fpsyt.2019.00955 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Population | Online survey respondents |
| Topics | Addiction Cannabis MDMA Psilocybin |
| Keywords | Stimulant Harm reduction Hallucinogen Heroin Clinical psychology Drug |
| Citations | 155 |
| Key findings | Psychedelic use is associated with self-reported reductions in problematic substance use, though causality cannot be determined from this study design. |
Abstract
While these cross-sectional and self-report methods cannot determine whether psychedelics caused changes in drug use, results suggest the potential that psychedelics cause reductions in problematic substance use, and support additional clinical research on psychedelic-assisted treatment for SUD.
In the evidence
This study is part of the evidence base for 3 syntheses in the library. Here is how each one recorded it.
-
Psychedelic use was associated with self-reported reductions in problematic substance use, though the design cannot determine causality.
Synthesized
-
Psychedelic use was associated with self-reported reductions in problematic substance use, though causality cannot be determined from this design.
Synthesized
-
Psychedelic use was associated with self-reported reductions in problematic substance use, though the design cannot determine causality.
Synthesized
Comparable studies
Other cross-sectional and survey studies on cannabis for addiction, most cited first.